Status:
UNKNOWN
AUTOLOGOUS FIBRIN GLUE VERSES 4-0 SILK SUTURES IN PERIODONTAL FLAP CLOSURE
Lead Sponsor:
KLE Society's Institute of Dental Sciences
Conditions:
Periodontitis
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
PHASE3
Brief Summary
The study is a split mouth study but the interventions for the two different arms will be spaced by a fixed duration in time. Verbal and written consent will be obtained from the patients fulfilling t...
Eligibility Criteria
Inclusion
- Patients diagnosed with periodontitis, with good systemic health and presence of a minimum of 3 teeth with periodontal pocket depth (PPD) of ≥6mm and clinical attachment level (CAL) of ≥5mm (stage 3 periodontitis as described by the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Condition and published by the American Academy of Periodontology) in at least two quadrants will be selected.
Exclusion
- Patients who have undergone periodontal therapy during the previous 6 months, or exhibit poor plaque control after phase I therapy.
- History of any systemic disease such as diabetes mellitus, hypertension,osteoporosis, unstable or life-threatening conditions, bleeding disorder, undergoing antibiotic or other antimicrobial therapy.
- Patients on drugs like aspirin, blood thinners and anticoagulant therapy
- Patients with history of allergy
- Current or former smokers.
- Mobility of selected teeth.
- Pregnant or lactating women.
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03792113
Start Date
May 1 2019
End Date
December 1 2020
Last Update
February 5 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.